The US, UK, Japan, and EU have already signed contracts to supply 1.3 billion doses of COVID-19 medicine.
Although the coronavirus vaccine has not yet gone on sale, even when it does, it is unlikely to become available for large-scale vaccination in the world.
This is because the world's wealthiest countries-the the US, UK, Japan, and the EU-have already reserved 1.3 billion doses of COVID-19 medicine for themselves, Bloomberg writes.
In addition, referring to data from the analytical company Infinity, future contracts may add another 1.5 billion doses to this figure.
And given that, according to the model developed by analysts, 1 billion doses of the vaccine will be ready only by the first quarter of 2022, poor countries will have a decent time to вЂњstand in lineвЂќ for the drug.
It is worth noting that the analysis took into account only the capabilities of Western biotech companies-Sanofi, Glaxo, Pfizer, and AstraZeneca. The achievements of Russia, which is going to start producing the vaccine in December, were not taken into account.
At the same time, the World Health Organization, the coalition for innovation in epidemic preparedness, and the Vaccine Alliance are working to ensure fair and widespread access to the COVID-19 vaccine worldwide. In June, they developed an 18-billion-dollar plan with the goal of providing 2 billion doses by the end of 2021.